Granulomatous rash associated with mogamulizumab mimicking mycosis fungoides: a case series
Eur J Cancer
.
2021 Oct:156 Suppl 1:S49.
doi: 10.1016/S0959-8049(21)00716-4.
Authors
Jingying Wang
1
,
Adèle de Masson
2
,
Caroline Ram-Wolff
2
,
Gabor Dobos
3
,
Jana Al Hage
2
,
Jacqueline Rivet
4
,
Marie-Dominique Vignon-Pennamen
4
,
Hélène Moins-Teisserenc
5
,
Marie Boisson
6
,
Aurelie Sadoux
6
,
Samia Mourah
6
,
Maxime Battistella
4
,
Martine Bagot
2
Affiliations
1
Dermatology Department, APHP, Saint-Louis Hospital, Paris, France; Department of Dermatology, Ruijin Hospital, Université Jiaotong de Shanghai, Shanghai, China.
2
Dermatology Department, APHP, Saint-Louis Hospital, Paris, France.
3
Dermatology Department, APHP, Saint-Louis Hospital, Paris, France; Department of Dermatology, Venerology and Allergology, Charité-Universitaetsmedizin Berlin, Berlin, Germany.
4
Pathology Department, APHP, Saint-Louis Hospital, Paris, France.
5
Hematology Laboratory, Saint-Louis Hospital, APHP, Paris, France.
6
Tumor Genomics and Pharmacology Department, APHP, Saint-Louis Hospital, Paris, France.
PMID:
34649659
DOI:
10.1016/S0959-8049(21)00716-4
No abstract available
Keywords:
Mogamulizumab; Sézary syndrome; adverse effect; mycosis fungoides.